Published August 11, 2022
| Version v1
Patent
Open
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
Contributors
Patent applicant:
Description
Antisense polynucleotides and their use in pharmaceutical compositions to induce exon skipping in targeted exons of the gamma sarcoglycan gene are provided, along with methods of preventing or treating dystrophic diseases such as Limb-Girdle Muscular Dystrophy.
Files
US20220251559.pdf
Files
(6.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:79d4c7e9697ae7f46b6b127d542606ce
|
6.4 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 202217727376 A
- Patent number
- US 2022/0251559 A1
- Other
- oai:uchicago.tind.io:9068
Dates
- Patent filed
-
2022-04-22